Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |